» Articles » PMID: 35872511

Coronavirus Disease 2019 and the Placenta: A Literature Review

Overview
Journal Placenta
Publisher Elsevier
Date 2022 Jul 25
PMID 35872511
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has been implicated in the clinical pathology of multiple organs and organ systems. Due to the novelty of the disease, there is a need to review emerging literature to understand the profile of SARS-CoV-2 in the placenta. This review sought to evaluate the literature on the mediators, mechanism of entry, pathogenesis, detection, and pathology of SARS-CoV-2 in the placenta. Systematic literature searches found 96 eligible studies. Our review revealed that SARS-CoV-2 canonical mediators, angiotensin-converting enzyme-2 (ACE2), and transmembrane serine protease-2 (TMPRSS2) are variably expressed in various placenta compartments, including the villous cytotrophoblasts, syncytiotrophoblasts (STBs), and extravillous trophoblasts (EVTs) throughout pregnancy. Placental SARS-CoV-2 and coronavirus-associated receptors and factors (SCARFs), including basigin (BSG/CD147), dipeptidyl peptidase-4 (DPP4/CD26), cathepsin B/L (CTL B/L), furin, interferon-induced transmembrane protein (IFITM1-3), and lymphocyte antigen 6E (LY6E) may increase or reduce the permissiveness of the placenta to SARS-CoV-2. EVTs express genes that code for proteins that may drive viral pathogenesis in the placenta. Viral RNA, proteins, and particles were detected primarily in the STBs by in situ hybridization, immunohistochemistry, electron microscopy, and polymerase chain reaction. Placental pathology in SARS-CoV-2-infected placentas included maternal and fetal vascular malperfusion and a generally nonspecific inflammatory-immune response. The localization of SARS-CoV-2 receptors, proteases, and genes involved in coding proteins that drive viral pathogenesis in the placenta predisposes the placenta to SARS-CoV-2 infection variably in all pregnancy trimesters, with antecedent placental pathology. There is a need for further studies to explicate the mechanism of entry and pathogenesis of SARS-CoV-2 in the placenta.

Citing Articles

Transplacental Transmission of SARS-CoV-2: A Narrative Review.

Bui M, Nguyen Le C, Duong K, Hoang V, Nguyen T Medicina (Kaunas). 2024; 60(9).

PMID: 39336558 PMC: 11434576. DOI: 10.3390/medicina60091517.


Evaluation of the effect of SARS-CoV-2 infection on Doppler ultrasound and placental findings of pregnant women: a systematic review and meta-analysis.

Chen L, Yin T, Cai D, Chen X Ultrasonography. 2024; 43(6):424-437.

PMID: 39318337 PMC: 11532520. DOI: 10.14366/usg.24038.


Severe Acute Respiratory Syndrome Coronavirus 2 Infection Symptoms in Pregnancy and Maternal and Neonatal Complications Due to COVID-19: A Systematic Review.

Miraj S, Asgarian A, Mohammadbeigi A, Derakhshani M J Hum Reprod Sci. 2023; 16(2):90-98.

PMID: 37547094 PMC: 10404020. DOI: 10.4103/jhrs.jhrs_135_22.


Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and TNF-alpha expression.

Bachnas M, Putri A, Rahmi E, Pranabakti R, Aggraini N, Astetri L AJOG Glob Rep. 2023; :100234.

PMID: 37362630 PMC: 10257336. DOI: 10.1016/j.xagr.2023.100234.


Association between SARS-CoV-2 infection and newly diagnosed hypertension during pregnancy: prospective, population based cohort study.

Ortqvist A, Magnus M, Dahlqvist E, Soderling J, Johansson K, Sandstrom A BMJ Med. 2023; 2(1):e000465.

PMID: 37275554 PMC: 10230329. DOI: 10.1136/bmjmed-2022-000465.


References
1.
Roland M, Friis C, Voldner N, Godang K, Bollerslev J, Haugen G . Fetal growth versus birthweight: the role of placenta versus other determinants. PLoS One. 2012; 7(6):e39324. PMC: 3377679. DOI: 10.1371/journal.pone.0039324. View

2.
Varghese P, Tsolaki A, Yasmin H, Shastri A, Ferluga J, Vatish M . Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology. 2020; 225(6):152008. PMC: 7434692. DOI: 10.1016/j.imbio.2020.152008. View

3.
Leon-Juarez M, Martinez-Castillo M, Gonzalez-Garcia L, Helguera-Repetto A, Zaga-Clavellina V, Garcia-Cordero J . Cellular and molecular mechanisms of viral infection in the human placenta. Pathog Dis. 2017; 75(7). PMC: 7108519. DOI: 10.1093/femspd/ftx093. View

4.
Facchetti F, Bugatti M, Drera E, Tripodo C, Sartori E, Cancila V . SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta. EBioMedicine. 2020; 59:102951. PMC: 7430280. DOI: 10.1016/j.ebiom.2020.102951. View

5.
Sanchez J, Vigil-De Gracia P, Guerrero E, Gaitan M, Fu C, Chen-German M . Severe acute respiratory syndrome coronavirus 2 detected in placentas of 2 coronavirus disease 2019-positive asymptomatic pregnant women-case report. AJOG Glob Rep. 2021; 1(1):100001. PMC: 7838577. DOI: 10.1016/j.xagr.2020.100001. View